Announcements
- Launch of new Company Long Term Incentive Plan
- Appointment of Non-Executive Director
- Progression of patient cohorts in PROTECT Trial
- Successful meetings with Paul Ehrlich Institut
- Allergy Therapeutics presents findings at EAACI
- Further detail from G306 Phase III field trial
- Director Resignation
- Interim Results for six months ended 31 Dec 2023
- Update on funding
- VLP Peanut PROTECT Trial Update
More ▼
Key statistics
On Friday, Allergy Therapeutics PLC (HHU:MUN) closed at 0.063, -3.08% below its 52-week high of 0.065, set on Jul 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.063 |
---|---|
High | 0.063 |
Low | 0.063 |
Bid | 0.0495 |
Offer | 0.0635 |
Previous close | 0.063 |
Average volume | 400.00 |
---|---|
Shares outstanding | 4.77bn |
Free float | 336.83m |
P/E (TTM) | -- |
Market cap | 226.41m GBP |
EPS (TTM) | -0.0266 GBP |
Data delayed at least 15 minutes, as of Jul 05 2024 07:15 BST.
More ▼